Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Esperion Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ESPR.
You can purchase shares of Esperion Therapeutics (NASDAQ:ESPR) through any online brokerage.
Other companies in Esperion Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), SNDL (NASDAQ:SNDL), Bioage Labs (NASDAQ:BIOA) and Rapport Therapeutics (NASDAQ:RAPP).
Esperion Therapeutics has a consensus price target of $5.83.
The stock price for Esperion Therapeutics (NASDAQ: ESPR) is $0.955 last updated April 17, 2025 at 7:56 PM EDT.
There are no upcoming dividends for Esperion Therapeutics.
Esperion Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Esperion Therapeutics.
Esperion Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.